81 related articles for article (PubMed ID: 10072514)
1. IL-4 preferentially activates a novel STAT6 isoform in mast cells.
Sherman MA; Secor VH; Brown MA
J Immunol; 1999 Mar; 162(5):2703-8. PubMed ID: 10072514
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
3. Mast cell-restricted p70 Stat6 isoform is a product of selective proteolysis.
Shelburne CP; Piekorz RP; Bouton LA; Chong HJ; Ryan JJ
Cytokine; 2002 Sep; 19(5):218-27. PubMed ID: 12393168
[TBL] [Abstract][Full Text] [Related]
4. IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6-dependent mechanism.
Ryan JJ; DeSimone S; Klisch G; Shelburne C; McReynolds LJ; Han K; Kovacs R; Mirmonsef P; Huff TF
J Immunol; 1998 Dec; 161(12):6915-23. PubMed ID: 9862725
[TBL] [Abstract][Full Text] [Related]
5. IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway.
Aronica MA; Goenka S; Boothby M
Cytokine; 2000 Jun; 12(6):578-87. PubMed ID: 10843732
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4-triggered, STAT6-dependent production of a factor that induces mouse mast cell apoptosis.
Hu ZQ; Zhao WH; Shimamura T; Galli SJ
Eur J Immunol; 2006 May; 36(5):1275-84. PubMed ID: 16598817
[TBL] [Abstract][Full Text] [Related]
7. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
White ED; Andrews RP; Hershey GK
J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
[TBL] [Abstract][Full Text] [Related]
8. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
[TBL] [Abstract][Full Text] [Related]
9. IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast co-culture through a Stat6 signaling pathway in fibroblasts.
Nabeshima Y; Hiragun T; Morita E; Mihara S; Kameyoshi Y; Hide M
FEBS Lett; 2005 Dec; 579(29):6653-8. PubMed ID: 16298365
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 induces two distinct GAS-binding complexes containing STAT6: evidence for DNA binding of STAT6 monomer.
Lee CE; Park HJ
Mol Cells; 2001 Feb; 11(1):28-34. PubMed ID: 11266117
[TBL] [Abstract][Full Text] [Related]
11. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Murata T; Taguchi J; Puri RK; Mohri H
Int J Hematol; 1999 Jan; 69(1):13-20. PubMed ID: 10641437
[TBL] [Abstract][Full Text] [Related]
12. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
[TBL] [Abstract][Full Text] [Related]
13. PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoter.
Pesu M; Aittomäki S; Välineva T; Silvennoinen O
Eur J Immunol; 2003 Jun; 33(6):1727-35. PubMed ID: 12778491
[TBL] [Abstract][Full Text] [Related]
14. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts.
Kriebel P; Patel BK; Nelson SA; Grusby MJ; LaRochelle WJ
Oncogene; 1999 Dec; 18(51):7294-302. PubMed ID: 10602484
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes.
Tuomela S; Rautajoki KJ; Moulder R; Nyman TA; Lahesmaa R
Proteomics; 2009 Feb; 9(4):1087-98. PubMed ID: 19180534
[TBL] [Abstract][Full Text] [Related]
16. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
17. SHP-1 regulates STAT6 phosphorylation and IL-4-mediated function in a cell type-specific manner.
Huang Z; Coleman JM; Su Y; Mann M; Ryan J; Shultz LD; Huang H
Cytokine; 2005 Feb; 29(3):118-24. PubMed ID: 15613279
[TBL] [Abstract][Full Text] [Related]
18. Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production.
Negrão-Corrêa D; Pinho V; Souza DG; Pereira AT; Fernandes A; Scheuermann K; Souza AL; Teixeira MM
Int J Parasitol; 2006 Sep; 36(10-11):1185-95. PubMed ID: 16793046
[TBL] [Abstract][Full Text] [Related]
19. IL-4-Stat6 signaling induces tristetraprolin expression and inhibits TNF-alpha production in mast cells.
Suzuki K; Nakajima H; Ikeda K; Maezawa Y; Suto A; Takatori H; Saito Y; Iwamoto I
J Exp Med; 2003 Dec; 198(11):1717-27. PubMed ID: 14638848
[TBL] [Abstract][Full Text] [Related]
20. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
